Alere loses $290M in market value ahead of Abbott acquisition

After losing about $290 million in market value this week due to a subpoena from the U.S. Department of Justice, Waltham diagnostics firm Alere this morning issued a statement defending the safety of its anticoagulation monitoring technology...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.